• Cy3 Goat Anti-Human IgG (H+L) Antibody in Advanced Immunoass

  2026-08-03

  The Cy3 Goat Anti-Human IgG (H+L) Antibody stands out for sensitive, multiplexed human IgG detection across immunofluorescence, immunohistochemistry, flow cytometry, and ELISA. This article details protocol enhancements, troubleshooting strategies, and cross-domain insights informed by recent advances in orthopoxvirus antibody research.

• Griseofulvin: Microtubule Associated Inhibitor for Antifunga

  2026-08-03

  Griseofulvin is a microtubule associated inhibitor with a well-characterized antifungal mechanism, acting via disruption of fungal cell mitosis. Its solubility profile and 98% purity make it a reference standard for microtubule dynamics research. Evidence supports its use in genotoxicity profiling and mechanistic assays.

• Dual Inhibition of FUBP1 and Topoisomerase I by SN-38 in Can

  2026-08-02

  This study demonstrates that camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit not only DNA topoisomerase I but also the binding of the oncogenic transcription factor FUBP1 to its DNA target, FUSE. These findings introduce a dual mechanism of action that may inform more targeted approaches in advanced colon and hepatocellular carcinoma research.

• Prochlorperazine-Induced Neuroleptic Malignant Syndrome: Cli

  2026-08-01

  This article examines a recent case report detailing neuroleptic malignant syndrome (NMS) precipitated by prochlorperazine in a geriatric patient. The study highlights the diagnostic challenges and therapeutic strategies for prochlorperazine-induced NMS, emphasizing the importance of early recognition and individualized management.

• Losartan (SKU B1072): Reliable Data-Backed Solutions in Vasc

  2026-07-31

  This article provides evidence-driven guidance for biomedical researchers and laboratory teams employing Losartan (SKU B1072) in cell viability, proliferation, and mechanobiology assays. Drawing on validated workflows and recent literature, it addresses common pitfalls and demonstrates how APExBIO's Losartan ensures reproducibility, sensitivity, and practical compatibility in advanced cardiovascular and tumor microenvironment studies.

• AP-1 Inhibition Induces Ferroptosis via PI3K/AKT in Myeloma

  2026-07-31

  This study demonstrates that the C-Fos/AP-1 inhibitor T-5224 triggers ferroptosis in multiple myeloma cells by downregulating the PI3K/AKT pathway, a mechanism distinct from apoptosis. These findings provide new mechanistic insights into potential therapeutic strategies for resistant multiple myeloma.

• Telmisartan in Cardiovascular Disease Research: Mechanisms a

  2026-07-30

  Explore the multifaceted role of Telmisartan as an angiotensin II receptor antagonist in cardiovascular disease research. This article delivers new insights into assay design, signaling pathway modulation, and practical lab parameters for translational hypertension studies.

• Rhodamine B: Advanced Fluorescent Probe for Cell and Environ

  2026-07-30

  Rhodamine B (Basic Violet 10) excels as a dual-use fluorescent probe, powering both high-sensitivity cell labeling and robust environmental tracer studies. This article details optimized protocols, troubleshooting strategies, and novel research workflows that maximize the dye’s performance and reproducibility in diverse scientific applications.

• Pertussis Toxin: AB5 Exotoxin for Immune Modulation Studies

  2026-07-29

  Pertussis toxin is a well-characterized AB5-type protein exotoxin used to dissect cAMP-dependent immune response modulation in preclinical models. Its effects on dendritic cell maturation and vascular reactivity are dose- and context-dependent. High-purity APExBIO Pertussis toxin enables reproducible immunological and signal transduction research.

• Alda 1 as an ALDH2 Activator: Protocols and Breakthrough Use

  2026-07-29

  Alda 1 enables precise activation of ALDH2, unlocking new avenues for cardiac regeneration and radiation-induced injury mitigation. This article delivers actionable protocols, troubleshooting insights, and a translation of cutting-edge research into practical workflows that maximize the value of Alda 1 in experimental studies.

• GPR107 Deficiency Accelerates Diabetic Nephropathy via AT1R

  2026-07-28

  Xu et al. reveal that loss of GPR107 in podocytes impairs AT1 receptor internalization, intensifying angiotensin II signaling and collagen IV accumulation in diabetic nephropathy. These findings identify a novel regulatory mechanism linking endocytosis, extracellular matrix homeostasis, and hypertension pathways in diabetic kidney disease.

• LOX-1–Mediated Redox Pathways in Angiotensin II-Induced Angi

  2026-07-28

  This study elucidates how Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) promotes capillary formation from endothelial cells via a LOX-1–dependent, redox-sensitive signaling pathway. The findings reveal a positive feedback loop between LOX-1 and Angiotensin II type 1 receptor (AT1R), with implications for understanding vascular remodeling and angiogenesis in pathological contexts.

• ALDH2 Activation Promotes Cardiomyocyte Proliferation in Hea

  2026-07-27

  This study demonstrates that activating ALDH2 extends cardiomyocyte proliferative capacity and delays pressure overload-induced heart failure in mice. These findings provide new mechanistic evidence for targeting ALDH2 to enhance cardiac regeneration, with translational implications for heart failure research.

• Hypoxia and Immunometabolism in Tumors: Mechanistic Insights

  2026-07-27

  This review explores how hypoxia-driven metabolic reprogramming and immunometabolic adaptation orchestrate the immunosuppressive tumor microenvironment. The article highlights the multifaceted mechanisms by which oxygen deprivation and metabolic competition influence immune cell function and shape therapeutic opportunities.

• Microsecond Pulsed Electric Fields: Mitochondrial Damage in

  2026-07-26

  This study reveals that microsecond pulsed electric fields (μsPEFs) ablate cardiomyocytes primarily through secondary mitochondrial injury and apoptosis, advancing the mechanistic understanding of non-thermal ablation for atrial fibrillation. The findings establish voltage and pulse thresholds for effective ablation and highlight the central role of mitochondrial dysfunction.

449 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page